Introduction
The human gut microbiota consists of trillions of individual bacteria and the interaction of this dense microbial population with our diet and other environmental factors is an important determinant of our health. A healthy microbiome is protective against a number of conditions including colon cancer (Zackular et al., 2013) , inflammatory bowel disease (Rajilic-Stojanovic et al., 2013; De Cruz et al., 2015) , diabetes (Forslund et al., 2015) and obesity (Ridaura et al., 2013) . Saccharolytic gut bacteria offer particular benefits, persisting in the host through the fermentation of fiber, carbohydrates that human enzymes are unable to process (Shanahan et al., 2017) . One prominent fiber in the human diet is resistant starch, starches that for a variety of reasons are indigestible by human enzymes, but are susceptible to attack by certain microorganisms (Birt et al., 2013) . Uncooked potato starch is one such resistant starch as it adopts an alternative crystal structure, known as the B-type structure, than that of the more easily digestible wheat and corn starches (Imberty et al., 1991) . In corn, certain mutations result in a higher relative abundance of amylose in the starch granules. This high amylose corn starch also adopts the B-type crystalline structure and is a resistant starch (Gallant et al., 1992) . The end result of resistant starch and other carbohydrate fermentation in the gut is often organic acids, particularly the short chain fatty acids (SCFA) acetate, propionate and butyrate (Rios-Covian et al., 2016) .
While SCFAs have been shown to influence our physiology (Berggren et al., 1996; Wong et al., 2006; Boets et al., 2017) , butyrate has been particularly noted for its health promoting effects (Guilloteau et al., 2010) . This SCFA can provide as much as 10% of our daily caloric intake (McNeil, 1984) and it is the preferred energy source of colonocytes (Roediger, 1980) . Butyrate increases the rate of proliferation of colonocytes and strengthens tight junctions (Wang et al., 2012) , improving gut barrier function. It increases the rate of apoptosis for malignant cells, protecting against colon cancer (Fung et al., 2012) . Butyrate also downregulates the expression of pro-inflammatory cytokines, leading to lower levels of inflammation in the gut (Nastasi et al., 2015) . When processed in the liver, butyrate shifts glucose metabolism toward storage as glycogen (Beauvieux et al., 2008) , thereby protecting against the development of diabetes. Thus, butyrate is clearly a critical regulator of health making it important to understand the unique physiology of the bacteria responsible for its production.
One of the most prominent groups of butyrateproducing organisms in the gut is the cluster XIVa clostridia, exemplified by one of their most abundant members, Eubacterium rectale. This Gram positive organism has long been recognized as a dominant species in the human gut (Gossling and Slack, 1974 ) and a core member of the healthy microbiome (Tap et al., 2009 ). E. rectale decreases in abundance in a number of disease states, including obesity (Haro et al., 2016) , inflammatory bowel disease (Kang et al., 2010; Rajilic-Stojanovic et al., 2013) , diabetes (Qin et al., 2012) and cystic fibrosis (Bruzzese et al., 2014) . Intriguingly, E. rectale levels are found to increase, along with butyrate levels, in diets rich in resistant starch (Martínez et al., 2010; Martínez et al., 2013) . However, in vitro studies indicate that it is unable to directly use resistant starch, although it grows robustly in the presence of a primary resistant starch degrader such as Ruminococcus bromii (Ze et al., 2012) . Our recent study of the cell wall and membrane proteome of E. rectale when grown on starch as compared to glucose, revealed that two ABC transporters that target different maltooligosaccharides, along with two amylases were strongly upregulated in the presence of starch. Thus, we proposed a model by which the larger cell surface amylase EUR_21100 plays a crucial role in the organism's growth on starch, cleaving starch molecules into maltotetraose and larger oligosaccharides, which is directly bound by the ABC transporter solute-binding protein EUR_01830 (Cockburn et al., 2015b) . Here, we present a structural and functional characterization of the cell surface amylase EUR_21100, which we have renamed Amy13K and demonstrate empirically that Amy13K contains five discrete starch-binding CBMs that establish two new CBM families and are critical for starch processing. These new CBM families exhibit an extremely narrow taxonomic distribution, suggesting that they are highly adapted to the niche of E. rectale in the human gut. These CBMs effectively target corn starch, including high amylose corn starch, but bind poorly to potato starch, explaining the weak activity of the enzyme against this substrate and why the organism cannot grow on resistant potato starch.
Results

Amy13K harbors CBMs that define novel families
We previously reported that E. rectale Amy13K (EUR_21100) was likely comprised of five CBMs at its Nterminus based on weak sequence homology to the starch-binding families CBM26 (BLAST E-value 2e
25
) and CBM41 (BLAST E-value 1e 25 -5e
27
) (Cockburn et al., 2015b) . The biochemical and structural data presented here supports that there are five CBMs, labeled as CBMa-e and two warrant classification into new CBM families ( Fig. 1) within the Carbohydrate Active enZymes database: www.cazy.org (Lombard et al., 2014) . CBMb and CBMc showed similarity to several CBM26 modules (Supporting Information Fig. S1 ) allowing them to be placed in this family. Similarly CBMd showed relatedness to several CBMs classified as CBM41 and, thus, was assigned to that family (Supporting Information Fig. S2 ). CBMa and CBMe did not show similarity to known CBM families or to each other. A BLAST search was then conducted against full length proteins in CAZy to identify similar domains. CBMa and its homologs (Supporting Information Fig. S3 ) were classified in a new CBM family called CBM82 while CBMe and its homologs define family CBM83 (Supporting Information Fig. S4 ).
The sequences of CBMb and CBMc identify them as members of the CBM26 family and their structures presented here (later in Fig. 3 ) point to their structural relationship to members of this family as well. The CBM26 domains are typically associated with a-amylases, including enzymes from bacteria related to E. rectale (Ramsay et al., 2006) . According to Pfam (pfam.xfam.org) CBM26s occur in tandem repeats approximately one third of the time. Conversely, CBMd can be placed within the CBM41 family, although it is a somewhat distant relative, exhibiting only a 28% sequence identity with its closest relative within the family. Despite this, it can be placed within subfamily 5 of this group, which includes the T. maritima PulA CBM41, its closest structural homologue (Janecek et al., 2017) . This group is characterized by the pattern of its aromatic residues with W-X-W-30aa-W, with the first tryptophan acting as a hydrogen-bonding residue, while the second and third form the aromatic binding platform for starch recognition. These residues are W416, W418 and W469 in CBMd. While the 51 amino acid distance between the second and third tryptophan is larger than the typical distance seen in this subfamily, there is some variability in this distance (Janecek et al., 2017) . This atypical distance and the overall low sequence identity with its fellow family members may be due to the fact that there are no prior examples of CBM41s from organisms closely related to E. rectale, as the CBMs in this family cluster along taxonomic lines (Janecek et al., 2017) . Intriguingly Pfam indicates that CBM41s occur as tandem pairs a slight majority of the time. This suggests that the new CBM82 family may be evolutionarily related to CBM41 and has diverged over time. In general the CBM41 family of binding domains is typically associated with pullulanases, that is, a-1,6 specific enzymes. The catalytic domain of Amy13K is related to the pullulanase subfamilies (GH13_12 and GH13_14) (Cockburn et al., 2015b; Møller et al., 2016) , although the enzyme itself is an a-amylase, that is, a-1,4 specific (Cockburn et al., 2015b) and assigned to subfamily GH13_41. Interestingly the GH13_41 domains are typically found in multidomain proteins in conjunction with one of the pullulanase families mentioned above (Møller et al., 2016) suggesting GH13_41 may have arisen from duplication of the pullulanase domains followed by further evolution or vice versa.
Intriguingly CBMa and CBMe each represent novel, previously uncharacterized CBM families. Their narrow distribution among similar gut bacteria within the Lachnospiraceae points to the highly specialized nature of these binding modules. Having a single large enzyme with a variety of adapted starch specific CBMs seems to be employed by a number of members of the Lachnospiraceae. Both Roseburia inulinovorans and Butyrivibrio fibrosolvens possess a large cell-associated amylase (Ramsay et al., 2006) . The catalytic domain of Amy13K and R. inulinovorans Amy13a both belong to the GH13_41 subfamily and the Amy13K_CBMa has a strong resemblance to the N-terminal R1 and R2 domain of Amy13a and together are part of the newly defined family CBM82 (Supporting Information Fig. S3) . Additionally, the previously described PUD domain (now CBM41) of Amy13a, is similar to Amy13K_CBMd and both also have CBMs that are part of the new CBM83 family (Supporting Information Fig. S4 ). While both enzymes have large N-terminal regions upstream of their catalytic domains, these regions have little sequence similarity other than the domains already mentioned. In contrast the B. fibrosolvens protein has an entirely different domain organization with the catalytic domain at the Cterminus, followed by a pair of CBM26 domains. Thus, members of this family of bacteria seem to have diverged over time with regards to their machinery for starch digestion, perhaps as part of their segregation into subtly different niches within the gut.
Crystal structures of Amy13K CBMd (CBM41) and CBMbc (CBM26)
Crystallization trials of CBMde yielded crystals of CBMd alone after several months, suggesting flexibility between the domains inhibited crystal formation until proteolysis occurred. Attempts to produce crystals of CBMe alone were unsuccessful. The structure of Amy13K_CBMd was solved to a resolution of 2.20 Å (R work 5 23.4%, R free 5 25.7%) Table 1 revealing a b-sandwich fold like other CBM41 structures ( Fig. 2A) . A search of the DALI server suggests that the closest structural relatives of CBMd are the CBM41 domain of Thermotoga maritima pullulanase PulA (PDB 2J73, Z-score 5 10.6) (Lammerts van Bueren and Boraston, 2007) , which also shares 22% sequence identity and the CBM41 domains of Streptococcus pneumoniae alkaline amylopullanase SpuA (PDB 2J44, Z-score 5 9.3) (Lammerts Van Bueren et al., 2004b) . Overall the secondary structure elements of CBMd align well with those of the CBM41s from PulA and SpuA with the major differences confined to loop regions. An overlay of the structure of CBM41d with that of CBM41 in PulA with bound maltotriose (PDB 2J73) identified the putative starch-binding site by conservation with similar starch-binding residues in PulA (Fig. 2B) . In PulA, the aromatic platform comprised of W29 and W73 overlays well with residues W418 and W469 of CBMd. Likewise in CBMd, additional hydrogen-bonding to the hydroxyl oxygens of adjacent glucose residues may be supported by W416, K460 and D477, which are present as W27, K76 and D81 in PulA. As seen in many starchbinding proteins, the aromatic binding platform forms the classic convex angle that matches the helical pitch of amylose and amylopectin chains (Imberty et al., 1991) . This orientation is seen in diverse starch-binding proteins ranging from dedicated starch-binding proteins like SusD (Koropatkin et al., 2008) , to CBMs (Boraston et al., 2006) and surface binding sites on amylolytic enzymes (Cockburn and Svensson, 2016) .
We determined the crystal structure of CBMbc with maltoheptaose (2.01 Å , R work 5 18.9%, R free 5 20.0%) and without (2.10 Å , R work 5 20.8%, R free 5 23.2%; Table 1 Fig. 3A ). In the substrate bound structure, the maltoheptaose molecule bound to CBMb spans across adjacent asymmetric units and likely facilitated crystallization. The structures of the free and maltoheptaose bound proteins overlay well with an RMSD <0.4 Å for all Ca atoms, and, thus, no structural change occurs on ligand binding. Both CBMb and CBMc display bound A. Cartoon diagram of Amy13K_CBMd (PDB 6AZ5). The putative binding site residues are shown in green and the tryptophans of the binding site are labeled for orientation purposes.
B. An overlay of the carbohydrate binding sites of Amy13K_CBMd and the CBM41 from T. maritima pullulanase PulA (PDB 2J73). CBMd binding residues and labels are shown in green, while PulA CBM41 binding residues, bound carbohydrate and labels are shown in blue. maltoheptaose with some minor differences. Both CBMs possess a pair of aromatic residues at the center of the binding interface, however in CBMb these are a tyrosine (Y198) and a tryptophan (W208), while in CBMc they are a pair of tryptophans (W299, W314) ( Fig. 3B and C) . Comparing the CBMs, the phenol ring of Y198 overlays with the indole ring of W299, while there is a 2.4 Å separation between the relative positions of W208 and W314. In addition to the aromatic binding platform there are several conserved hydrogen bonds between the two CBMs. The Y196 and Y297 hydroxyl groups form hydrogen bonds with the O6 of the glucose stacking on Y198 and W299, respectively, while Q247 and Q352, form hydrogen bonds with both the O2 and O3 of the glucose stacked on W208 and W314 respectively. In CBMc N355 forms a hydrogen bond with the O3 of the glucose stacked on W299, however, the equivalent residue in CBMb, D250, has a water-mediated contact with the O2 of the glucose stacked on Y198. A loop spanning from K199 to P204 in chain A of CBMb diverges in position from the equivalent loop in CBMc (A301-A308) and forms contacts with the glucose residues of the maltoheptaose molecule as it spans into the neighboring asymmetric unit into the binding site of CBMc. This places E200 and N202 of CBMb chain A in hydrogen bonding position with the maltoheptaose molecule as it extends out of the CBMb binding site, potentially expanding the CBMb binding site ( Fig. 3B and Supporting Information Fig. S5 ). The equivalent loop in CBMc from A301 to A308 is composed of smaller sidechains, packing into the body of the CBM and does not appear to be capable of making additional contacts to a longer sugar.
Like CBMd, both CBMb and CBMc exhibit the typical b-sandwich fold seen in many CBMs (Fig. 3A) . DALI searches reveal that the closest structural matches for CBMb/c are the CBM25 (2C3X, Z-score 5 11.7/10.5) D. An overlay of Amy13K_CBMb and the CBM26 from Bacillus halodurans aamylase G6 (PDB 2C3H). CBMb residues and bound carbohydrate are shown in green, while those for the B. halodurans CBM26 are shown in aqua.
E. An overlay of the carbohydrate binding sites of Amy13K_CBMb and the CBM26 from B. halodurans a-amylase G6 (PDB 2C3H). CBMb residues, carbohydrate and labels are shown in green, while those for CBM26 are shown in blue.
Novel CBMs dictate E. rectale starch utilization 253 and CBM26 (2C3H, Z-score 5 10.7/10.1) from Bacillus halodurans a-amylase (Boraston et al., 2006) along with the CBM25 from the Paenibacillus polymyxa b/a-amylase (PDB 2LAA, Z-score 5 10.7/10.1). Somewhat weaker matches are found to the CBM41 family of domains, despite our previous suggestion that CBMbc might be members of this family (Cockburn et al., 2015b ). An overlay with the CBM26 from B. halodurans (2C3H) shows a high degree of overlap between the aromatic platform residues from both CBMb and c, as well as some of the hydrogen bonding residues of these CBMs. Of note, Y196/Y297 from CBMb/c with Y23 from B. halodurans CBM26 as well as Q247/352 from CBMb/ c with Q71 from B. halodurans CBM26 ( Fig. 3D and E) are superimposable. Thus, it appears that CBMb and CBMc are most structurally homologous to CBM26, supporting their placement within this family.
Amy13K CBMs bind soluble starch and oligosaccharides
A total of six recombinant protein constructs were used in this study to test the ability of the Amy13K CBMs to bind to starch (Fig. 1) . The CBMs were expressed independently (e.g., CBMa) or in combination (e.g., CBMa-e) to examine how they might synergize to enhance starchbinding. Both affinity electrophoresis and isothermal titration calorimetry (ITC) were used to determine the binding of the constructs to polymers and smaller maltooligosaccharides. In affinity electrophoresis binding is monitored via migration of the protein through an acrylamide gel in the presence or absence of ligand and slower migration occurs as the protein interacts with polysaccharide (Abbott and Boraston, 2012; Cockburn et al., 2017) . By affinity electrophoresis, all of the CBM constructs except the CBMe construct displayed binding to both amylopectin and pullulan (Fig. 4) . While amylopectin is one of the two components of starch along with amylose, pullulan is a linear fungal cell wall polysaccharide composed of a-1,6 linked maltotriose residues. Like amylopectin, pullulan contains both a-1,4 and a-1,6 linkages, however, it is linear rather than branched and has a much greater frequency of a-1,6 bonds, occurring every three linkages (Prajapati et al., 2013) . Thus, it serves as a model substrate for de-branching enzymes and can be useful for determining the tolerance for and importance of a-1,6 linkages for binding (Cockburn et al., 2015a) . While CBMa and CBMbc display slower migration in the presence of amylopectin, which has longer regions of a1,4-linked glucan, the CBMde construct is slowed much more by the presence of pullulan. Enhanced binding to pullulan could be driven by specific interactions with CBMd or due to enhanced avidity from the tandem CBM construct.
Indeed, longer constructs such as CBMb-e and CBMa-e also displayed some enhanced binding to pullulan over amylopectin, either due to the presence of CBMde or by avidity. From the crystal structure of CBMd without substrate, it is difficult to speculate how this CBM may specifically accommodate a1,6 linkages, however, it may be the influence of the a1,6 bond on the surrounding structure that is recognized. The a1,6 bond introduces considerable structural flexibility relative to a1,4 bonds, resulting in pullulan behaving as a random coil in solution compared to the helices formed by amylose (Dais et al., 2001) . In starch, the branch points cause the creation of amorphous layers that alternate with the longer linear regions that make up the crystalline layers (Damager et al., 2010) . Thus, it takes 3-6 glucose residues after an a1,6 linkage before regular helices begin to form (Motawia et al., 2005) and it is possible that CBMd and or CBMe preferentially recognize these less ordered regions. In total, these data suggest some differences in the relative affinity and tolerance of the various CBMs toward a1,6 branch points in starch and likely help the enzyme recognize a variety of starch particles in the gut environment. As expected, none of the CBMs demonstrated binding to dextran (data not shown), an all a-1,6 polymer of glucose on which Amy13K lacks activity.
ITC was also utilized to determine the affinity of the CBMs to glycogen, maltoheptaose and b-cyclodextrin. Glycogen is a starch-like storage molecule in many animals and bacteria, and it is structurally similar to amylopectin with an increased a1,6-branch frequency making it much more soluble and, thus, easily used in ITC. Maltoheptaose represents a stretch of a-1,4 linked glucose with flexible geometry and typically longer than the binding surface of CBMs, while b-cyclodextrin is identical in composition to maltoheptaose but circular, with a curvature matching that seen in amylose (Imberty et al., 1991) . All of the CBM constructs tested exhibited binding to each of these ligands ( (Table 2 , values in parentheses) with CBMa displaying a binding site frequency of 2.3 mM/% glycogen, while CBMe is somewhat lower at 0.8 mM/% glycogen. Interestingly the dual CBM constructs diverge significantly in this regard with CBMbc displaying a binding site frequency of only 0.05 mM/% glycogen, while CBMde is at 2.4 mM/% glycogen, despite the similar affinities of these two constructs for glycogen. This higher frequency for binding sites for CBMde may suggest that these CBMs have a greater tolerance for the frequent a-1,6 branch points in glycogen in line with its greater affinity for pullulan in the AE gels (Fig. 4) . The longer constructs CBMb-e and CBMa-e seem to be limited by the CBMbc binding restrictions as they display similar binding site frequencies at 0.06 mM/% glycogen Novel CBMs dictate E. rectale starch utilization 255 and 0.1 mM/% glycogen, respectively, although with significantly better affinities. Thus, the combination of these CBMs provides high affinity binding, but perhaps at the cost of less frequent binding sites. Furthermore this appears to be driven not just by avidity effects and size of the construct, but also by differing binding specificities. 
Binding of CBMs to granular starch
In complement to binding studies with soluble substrates, the ability to interact with granular starch, which represents some of the starch that would be expected to traverse the distal gut, was investigated. In these adsorption assays, proteins and starch were incubated followed by centrifugation to determine the remaining concentration of unbound protein. Binding of the CBM constructs to standard cornstarch, whole grain corn starch, a high amylose corn starch (HiMaize 260), potato starch, and the chemically modified resistant starch Fibersym was tested (Table 3) . No binding was detected for whole grain corn starch (data not shown) likely because the starch itself is inaccessible due to the presence of the bran, making it a type-1 resistant starch (Birt et al., 2013) . It has not been tested if whole grain starch serves as a growth substrate for E. rectale, but this result suggests it is unlikely. Significant binding toward Fibersym was only evident for the CBMa-e, and CBMb-e constructs, suggesting that no single CBM domain drives affinity, rather avidity from multiple domains is required. With regular corn starch, similar binding was observed among the CBMa and CBMde constructs, while CBMbc displays threefold lower affinity. The pairing of these CBMs together in the longer constructs CBMa-e and CBMb-e did not significantly enhance binding, suggesting avidity is not as important for access to corn starch. However, for the highamylose starch HiMaize260, the longer CBMa-e and CBMb-e constructs displayed threefold-tenfold enhanced affinity over the smaller constructs. Surprisingly, the CBMa-e construct on average had lower affinity than the construct lacking only CBMa, despite the fact that CBMa binds HiMaize with similar affinity to the CBMbc and CBMde constructs. Thus, Amy13K CBMs seem to recognize high-amylose and mixed amylopectin/amylose corn starches with similar affinities. This was consistent across most of the CBM constructs tested, suggesting that these two forms of corn starch present similar binding surfaces to Amy13K.
Interestingly, the CBMs of Amy13K do not appreciably bind potato starch, with only slight binding observed for the largest CBM construct, and binding was not saturable. Relatively few studies have examined the difference in binding between corn starch and potato starch for amylolytic CBMs, although both the pig pancreatic amylase (Warren et al., 2011 ) and the barley a-amylase AMY1 (Cockburn et al., 2015a) have surface binding sites that seem to preferentially bind corn starch over potato starch. One interesting study found that for the A. niger CBM20 the affinity for potato starch and corn starch binding sites seemed to be the same, but there were far fewer of the binding sites available on the potato starch, resulting in a much lower apparent affinity (Paldi et al., 2003) . One point to note is that the approximately sevenfold difference in CBM20 binding sites in this study is significantly larger than the threefold difference in specific surface area between these two starch types (Warren et al., 2011) . This indicates that it is not just the size of the surface available for binding that differs, but also the frequency of structural binding motifs. Binding to the surface of starch granules is an important barrier to enzyme action as the granule interiors seem to be readily attacked (Gallant et al., 1992) , even by enzymes lacking CBMs or surface binding sites (Cockburn et al., 2015a) . Removal of the CBM(s) of the Microbacterium aurum a-amylase MaAmyA removed the ability of the enzyme to form pores in starch granules (Valk et al., 2015) . Interestingly, it was discovered that this enzyme possesses a novel type of CBM, which was assigned to the new CBM74 family (Valk et al., 2016) . This CBM is of particular interest as it displays a tenfold better affinity for potato starch compared to corn starch and is enriched in gut bacteria, particularly resistant starch degraders such as a variety of Bifidobacterium species and R. bromii. Thus, acquiring novel binding functionalities may be a key adaptation of potato starchdegrading organisms.
Activity of Amy13K and CBM truncation mutants
To probe the role of these CBMs on enzyme activity, the activity of the full-length (WT) enzyme was compared to that of truncation mutants lacking one, three or all five of the identified CBMs (Fig. 1) . In preliminary tests, constructs lacking three or all five CBMs displayed greatly reduced activity such that substrate saturation could not be attained, even when pushed to the maximum feasible levels. In addition, none of the enzyme constructs exhibited saturation kinetics for the potato starch. Therefore, we compared the catalytic efficiency (k cat /K M ) of these Novel CBMs dictate E. rectale starch utilization 257 constructs to focus on the role of these CBMs on starch hydrolysis.
To examine if removal of the CBMs affected activity of the enzyme overall, we measured the catalytic efficiency of the WT and DCBMa-e on maltoheptaose, as hydrolysis of this small substrate would not be subject to an avidity affect via the CBMs. The catalytic efficiency of the WT and DCBMa-e on maltoheptaose are 2.8 3 10 4 6 1.9 3 10 4 s 21 M 21 and 1.2 3 10 4 6 8.6 3 10 3 s 21 M 21 , respectively, suggesting that these truncated constructs have a slightly lower inherent activity as it is unclear how the CBMs could contribute to activity on a small substrate. However, with soluble starch amylopectin, the same twofold-threefold decrease in catalytic efficiency between the full-length enzyme and the constructs lacking various CBMs was observed, suggesting the CBMs are not required to enhance access to this substrate (Table 4) . This is despite the efficient binding of these CBMs to the similar substrate glycogen (Table 2) , suggesting a high affinity of the enzyme active site for amylopectin that is not further enhanced by the CBMs. Intriguingly, activity levels were similar for each construct toward both regular and high-amylose corn starch granules. This is in line with the binding assays for these substrates, and may suggest that the initial surface presented to the enzyme by these substrates is similar. For both regular and HiMaize corn starch there is a significantly higher dependence on the CBMs with the activity decreasing by an order of magnitude as the CBMs are removed. In contrast the potato starch, which has a low dependence on the CBMs, displayed an approximately threefold decrease in activity for the DCBMa-e enzyme compared to the WT enzyme. Most strikingly the enzymes lacking 3 or all 5 of the CBMs show similar activity toward the three insoluble starches, while the full length enzyme shows a much more dramatic decrease in catalytic efficiency between the corn starches and the potato starch. Potato starch adopts the B-type crystalline form, as opposed to the A-type form seen in most corn and wheat starches (Imberty et al., 1991) . High amylose corn starch such as the HiMaize 260 used in this study also adopts the B-type crystalline form and this may explain its resistance to degradation (Gallant et al., 1992) . Interestingly the Amy13K CBMs bind similarly to both regular corn starch and HiMaize260 and the enzyme exhibits similar activity toward the two substrates. This indicates that surface binding does not represent the barrier to efficient degradation (and hence growth) in this case as it does with potato starch. It should be noted that the activities measured in this study only represent the initial stages of degradation that occurs on the granule surface. It is possible that the total amount of starch susceptible to degradation by Amy13K is much smaller for HiMaize260 compared to regular corn starch, once the granule surface has been degraded.
One final construct was tested where all the identified CBMs as well as an additional 200 amino acids that occur between the CBMs and the predicted start of the GH13 catalytic domain, labeled as the unknown region in Fig. 1 , were removed. While we were able to obtain large amounts of this recombinant protein in a soluble form during expression in E. coli, it had no detectable activity, even toward soluble substrates and oligosaccharides. Secondary structure predictions (JPred4, http:// www.compbio.dundee.ac.uk/jpred/) (Drozdetskiy et al., 2015) do not indicate b-strand rich regions as are typically found in CBMs and there are no domains with ascribed function that match this sequence. However, this region clearly plays an important structural role in Amy13K, perhaps directly impacting the active site.
Discussion
Importance of CBMs for activity
It has been demonstrated that CBMs are important for targeting substrates in complex environments such as the plant cell wall (Herv e et al., 2010) and undoubtedly the breakdown of starch in the gut provides similar challenges. During in vitro studies the removal of a starch binding CBM20 abolished activity of the Aspergillus niger glucoamylase toward granular starch (Svensson et al., 1982) . Conversely, recombinantly fusing this CBM20 to the barley a-amylase AMY1 increased its activity toward granular starch sixfold (Juge et al., 2006) . This is despite the fact that AMY1, while lacking a CBM, has a pair of surface binding sites on its catalytic module, which have been shown to be important for its activity (Nielsen et al., 2009; Nielsen et al., 2012; Cockburn et al., 2015a) . In Amy13K, we have identified five CBMs that provide the enzyme with affinity for starch granules. Removal of these CBMs has little impact on the activity of the enzyme toward maltoheptaose or soluble amylopectin, but has a more dramatic effect on the activity toward cornstarch granules. Notably this difference disappears when examining activity toward potato starch, for which the CBMs have apparently less affinity. The protein lacking all five CBMs displays little discrimination between the three types of insoluble starches tested, suggesting that the CBMs account for the differences in activity against these substrates. The lower activity and lack of dependence on the CBMs for potato starch corresponds to the lack of binding seen for the isolated CBMs.
Implications for relationships with other gut microorganisms
Resistant starch represents an important substrate for the gut microbiota, while nonresistant starch is processed in the small intestine and, thus, does not reach the microbial populations of the large intestine. Potato and high amylose corn starch consist of about 40-80% resistant starch (depending on the specific type and method of measurement used) (McCleary and Monaghan, 2002) and, thus, a large proportion of these starches reach the colon. E. rectale alone is unable to grow on resistant starches, but grows well in coculture with resistant starch degraders such as Ruminococcus bromii (Ze et al., 2012) . Our results suggest that for potato starch it is the lack of efficient targeting by the CBMs of Amy13K that underpins the molecular basis for E. rectale's inability to grow on this substrate. This inefficient targeting seems to be entirely due to the granular structure of potato starch as purified and autoclaved potato amylopectin readily supports growth of E. rectale (Desai et al., 2016) and is efficiently bound by the Amy13K CBMs (Fig. 4) . Despite its limited ability to grow on resistant starches, people who consume resistant starch often have increased levels of E. rectale in their large intestine (Martínez et al., 2010; Martínez et al., 2013; Venkataraman et al., 2016) . While E. rectale has a suite of transporters specializing in the uptake of starch breakdown products (Cockburn et al., 2015b) , it would clearly be advantageous for the organisms to localize to this food source. E. rectale lacks accessory starch binding proteins such as those found in the starch utilization system (Sus) of Bacteroides thetaiotaomicron (Cameron et al., 2012; Foley et al., 2016) . Instead it is possible that the CBMs of the cell wall anchored Amy13K help localize the bacteria to resistant starches such as high amylose corn starch. Indeed E. rectale was found to colonize high amylose corn starch in an in vitro continuous flow system (Leitch et al., 2007) . E. rectale levels are enriched on diet supplementation with potato starch (Venkataraman et al., 2016) , but given the lack of binding to this starch by the Amy13K CBMs other means of localization may be needed or it is possible that enough soluble material is released by degraders to render binding to potato starch granules unnecessary. However, the affinity of these CBMs for potato amylopectin may indicate that on initial processing of potato starch, new binding sites are opened up for binding by Amy13K. The Amy13K CBMs do display weak binding to Fibersym, a Type IV, chemically modified resistant starch, however, a study with people consuming this starch did not find elevated levels of E. rectale (Martínez et al., 2010) . It is also currently unknown if this starch can directly support E. rectale growth or indirectly through crossfeeding with a primary degrader.
Conclusion.
We have identified and characterized the five CBMs of Amy13K, which allow the definition of two new CBM families. These CBMs bind efficiently to corn starch, including high amylose corn starch as well as amylopectin and maltooligosaccharides, but display little affinity for potato starch. The low affinity of these CBMs for granular potato starch may be a key factor in the low activity of Amy13K for this substrate and provides a molecular rationale for why this is a poor growth substrate for E. rectale. In contrast it seems that other factors are at play in limiting the ability of E. rectale to utilize high amylose corn starch as the surface binding and initial rates of degradation are similar to regular corn starch. It could be that following the initial surface erosion the binding motifs recognized by the Amy13K CBMs are eliminated decreasing affinity and activity to that seen with potato starch. Indeed, in previous work examining the ability of E. rectale to utilize corn starches, the bacterium can utilize less than 20% of high amylose corn starch when cultured with the raw granules that have not been heat treated (Ze et al., 2012) . Our results presented here provide important insight into the potential roles of CBMs in determining substrate utilization profiles in the human gastrointestinal tract.
Experimental procedures
Reagents
Primers used for cloning were synthesized by IDT DNA Technologies and are listed in Supporting Information Table   Novel CBMs dictate E. rectale starch utilization 259 S1. HiMaize260 starch and whole grain starch were kindly provided by Ingredion (Bridgewater, NJ, USA). FiberSym starch (MGP Ingredients) was a gift from Jens Walter (University of Alberta, Canada). All other chemicals were purchased from Sigma Aldrich, except where noted.
Cloning, protein expression and purification
All genes and gene fragments were amplified from E. rectale genomic DNA using the Phusion TM Flash polymerase (Thermo Fisher Scientific) according to the manufacturer's instructions and all primer sequences are listed in Supporting Information Table S1 . All genetic constructs used in this study were created using the ExpressoV R T7 Cloning system (Lucigen Inc.) according to the manufacturer's instructions and are listed in Supporting Information Table S2 . Expression plasmids were transformed into E. coli Rosetta (DE3) pLysS cells, expressed and purified as previously described (Cockburn et al., 2015b) . Selenomethionine substituted Amy13K_CBMbc was produced by first transforming the plasmid into E. coli Rosetta(DE3)/pLysS and plating onto LB supplemented with kanamycin (50 mg/ml) and chloramphenicol (20 mg/ml). The bacteria were grown for 16 h at 378C and then colonies were harvested from the plate to inoculate 100 ml of M9 minimal medium supplemented with the same antibiotics. After 16 h of incubation at 378C this starter culture was used to inoculate a 2 l baffled flask containing 1 l of Molecular Dimensions SelenoMet premade medium supplemented with 50 ml of the recommended sterile nutrient mix, chloramphenicol and kanamycin. Cultures were incubated at 378C until an OD 600 of 0.45 was reached. At this point the temperature was adjusted to 208C and each flask was supplemented with 100 mg each of L-lysine, L-threonine and L-phenylalanine and 50 mg each of L-leucine, L-isoleucine, L-valine and Lselenomethionine (Van Duyne et al., 1993) . After 20 min of further incubation, protein expression was induced by the addition of 0.5 mM IPTG and cultures were allowed to grow for an additional 48 h before being harvested. Cells were then lysed and the protein purified as previously described via Ni 21 affinity chromatography (Cockburn et al., 2015b) .
Crystallization experiments
All proteins were subjected to a series of 96-well hanging drop sparse matrix screens to identify crystallization conditions. Selenomethionine-substituted crystals of Amy13k_CBMbc (54 mg/ml) were obtained via hanging drop vapor diffusion at room temperature against 1.5 M ammonium sulfate, 0.1 M Bis-Tris Propane, pH 7.0 (Hampton Research SaltRx). Native Amy13K_CBMbc crystals were obtained without (free) or with 14mM maltoheptaose via hanging drop experiments against 60% Tacsimate, 0.1 M Bis-Tris Propane, pH 7.0 (Hampton Research SaltRx), also at room temperature. Native Amy13K_CBMd crystals were obtained via hanging drop against 50% pentaerythritol propoxylate (5/4 PO/OH), 0.1 M Tris-HCl pH 8.0 in the Molecular Dimensions Midas screen using 20 mg/ml protein. All crystals used in this study were cryoprotected prior to freezing in liquid nitrogen by quickly swiping the crystal through a solution of 80% mother liquor supplemented with 20% ethylene glycol. X-ray data were collected at the Life Sciences Collaborative Access Team (LSCAT) beamline ID-D of the Advanced Photon Source at Argonne National Laboratory. Data were integrated using iMosFLM (Battye et al., 2011) and then indexed and scaled using the program Aimless (Evans and Murshudov, 2013) from the CCP4 package (Winn et al., 2011) . For the selenomethionine substituted Amy13K_CBMbc, phases were solved by single anomalous dispersion (SAD) using the AutoSol program of the Phenix package (Adams et al., 2010) . This structure was then used to solve the native Amy13K_CBMbc with or without maltoheptaose by molecular replacement using Phaser-MR (McCoy et al., 2007) within Phenix. In the substrate free structure, four molecules were found in the asymmetric unit, however, chain D exhibited higher mobility than the other chains and not all amino acid sidechains from Y297-I356 could be confidently fit to the electron density and were, thus, omitted. The Amy13K_CBMd structure was solved via sulfur SAD after merging seven datasets from three crystals with autoPROC (Vonrhein et al., 2011) and phasing in AutoSol. The resulting structure was then used to solve the structure from a single dataset via molecular replacement with Phaser-MR. Structures were refined using Phenix.refine (Afonine et al., 2012) . In the maltoheptaose bound structure of Amy13K_CBMbc the conformation of bound carbohydrates was validated using Privateer (Agirre et al., 2015) from the CCP4 package.
Enzyme activity assays
For activity assays with polysaccharide substrates the production of free reducing ends was monitored using the bicinchoninic acid (BCA) method (Waffenschmidt and Jaenicke, 1987) as previously described (Cockburn et al., 2015b) . All reactions included 10 mM HEPES pH 6.5, with 5 mM CaCl 2 and 0.02% Tween80. All granular starch substrates were washed 10x in pure water prior to activity assays. For activity toward amylopectin Amy13K_WT (2.2 nM), DCBMa (2.4 nM), DCBMa-c (3.0 nM) or DCBMae (4.0 nM) was incubated with six concentrations of potato amylopectin (0.003-0.5%). Reactions were monitored for 30 min. Initial velocities were calculated and fitted to a Michalis-Menten curve to calculate k cat and K M . For activity toward corn starch Amy13K_WT (3 nM), DCBMa (6 nM), DCBMa-c (15 nM) or DCBMa-e (26 nM) were incubated with six concentrations of granular corn starch (0.2-10%) and activity was monitored for 135 min. Initial velocities were plotted against substrate concentration and for WT and DCBMa the k cat and K M were derived through fitting to a Michalis-Menten curve. For DCBMa-c and DCBMa-e it was only possible to derive k cat /K M from the slope of the line. For activity toward HiMaize 260 starch, Amy13K_WT (4 nM), DCBMa (8 nM), DCBMa-c (20 nM) or DCBMa-e (40 nM) were incubated with six concentrations of granular HiMaize 260 high amylose corn starch (0.06-6%) and activity was monitored for 135 min. Initial velocities were plotted against substrate concentration and for WT and DCBMa the k cat and K M were derived through fitting to a Michalis-Menten curve. For DCBMa-c and DCBMa-e it was only possible to derive k cat /K M from the slope of the line. For activity toward potato starch, Amy13K_WT (1.1 nM), DCBMa (1.2 nM), DCBMa-c (1.5 nM) or DCBMa-e (2.0 nM) were incubated with six concentrations of granular potato starch (Bob's RedMill; 0.5-20%). Initial velocities were plotted against substrate concentration and k cat /K M was calculated from the slope of the line. Activity toward oligosaccharides was monitored via isothermal titration calorimetry. Amy13K_WT (11 nM) or DCBMa-e (20 nM) were placed into the cell of a standard volume Nano ITC (TA Instruments, New Castle, Delaware). Forty mM maltoheptaose was serially injected into the cell while stirring at 350 RPM at a temperature of 378C (see Supporting Information Table S3 for injection volumes and times). The molecular enthalpy of the reaction was calculated to be 4.41 kJ/mol by monitoring the complete conversion of 10 mM maltotetraose to maltose by 8 mg/ml Amy13B, formerly EUR_01860 (Cockburn et al., 2015b) in duplicate, which agreed well with previous estimates (Goldberg et al., 1991) . Catalytic parameters were determined using the NanoAnalyze software (TA instruments).
Isothermal titration calorimetry CBM binding assays
CBM binding to maltoheptaose, b-cyclodextrin and glycogen was determined by isothermal titration calorimetry (ITC) using a TA Instruments low volume NanoITC. For CBMa, 63 mM protein was titrated with 10 and 13 mM bcyclodextrin, 20 mM maltoheptaose or 1% and 2% glycogen (from rabbit liver). CBMbc was used at a concentration of 42 mM and titrated with 10 mM b-cyclodextrin, 10 and 25 mM maltoheptaose or 5% glycogen. The CBMde construct was at a concentration of 190 mM and titrated with 1 mM and 5 mM maltoheptaose, 2.5 mM b-cyclodextrin or 1%, 1.5% and 2% glycogen. CBMe was measured at 780 mM and titrated with 10 mM and 13 mM b-cyclodextrin, 20 mM maltoheptaose or 5% and 10% glycogen. CBMb-e was measured at 5 mM and titrated with 4 and 5 mM bcyclodextrin, 20 mM maltoheptaose or 0.5% and 1% glycogen. CBMa-e was measured at 7.8 mM and titrated with 2 or 4 mM b-cyclodextrin, 5 mM maltoheptaose or 1% and 2% glycogen. All data were analyzed using the manufacturer's NanoAnalyze software, using a constant blank correction and an independent binding model unless otherwise noted. To obtain K d values it was necessary to fix the value of n (number of binding sites) in these calculations. For maltoheptaose and b-cyclodextrin the value of n was fixed at the number of CBMs in the construct (e.g., 1 for CBMa, 2 for CBMbc). For glycogen the molar concentration of the ligand used was empirically set such that it produced a value for n of 1 when fitting the curve to the data. Thus, the concentration of glycogen used in this calculation represents the molar concentration of available binding sites on the polysaccharide ligand, according to the protocol of Abbott and Boraston (2012) . The binding site frequency (mM/% glycogen) for each construct was calculated as the slope of the concentration of binding sites over the w/v% of glycogen used. For example, the CBMb-e construct was assayed for binding at 0.5% and 1% glycogen. The binding site concentration (the concentration found to give n 5 1 during curve fitting) was 0.022 mM and 0.05 mM respectively. Calculating the slope (0.05-0.022)/(1-0.5) gives a binding site frequency of 0.056 mM/%glycogen (rounded to 0.06 in Table 2 ). This represents the concentration of binding sites for a particular construct, that is, how many copies can bind before reaching saturation for 1% w/v glycogen. Thus, we would expect lower numbers for larger constructs (each takes up more space) and for constructs that have a relatively infrequently occurring binding motif.
Starch binding assays
Binding of isolated CBMs to insoluble corn starch, whole grain starch, HiMaize 260 high amylose starch, potato starch or Fibersym chemically modified resistant starch was determined through protein depletion assays (Abbott and Boraston, 2012) . Prior to protein addition, the starch was washed two times with 10 mM HEPES pH 6.5, 150 mM NaCl. CBMs (80 mg/ml) were then incubated with 1-100 mg/ml starch for 10 min at room temp with end-overend rotation and insoluble material (including bound protein) was removed by two rounds of centrifugation at 20,000 3 g. Protein concentration in the supernatant (unbound) was then determined by the Bradford assay (Bio-Rad) according to the manufacturer's protocol, using the CBM construct under study as the protein standard. The fraction of protein bound to starch was then plotted against starch concentration to determine binding constants using the following formula:
Where B is the fraction of protein bound, B max is the maximum proportion of protein bound, [S] is the concentration of starch and K d is the dissociation constant.
Affinity electrophoresis
To investigate binding of CBMs to amylose, amylopectin, glycogen, pullulan and dextran, affinity electrophoresis was used (Abbott and Boraston, 2012; Cockburn et al., 2017) . Native polyacrylamide gels with and without added polysaccharide were compared for each CBM construct. Binding was considered positive if the migration of the protein in the polysaccharide gel relative to a noninteracting protein (bovine serum albumin) was significantly slower (<0.85 relative mobility) compared to that in the control gel. All polysaccharides were used at 0.1% final concentration. Gels were made at 12% acrylamide with 0.375 M Tris-HCl pH 8.8. Gels were subjected to 100 V for 4 h and then stained for 2 h with 0.1% Coomassie Brilliant Blue R-250 in 10% acetic acid, 50% methanol, 40% water, before destaining with solution lacking Coomassie overnight with one change of solution.
Bioinformatic analysis
The boundaries of the CBMs were determined from examination of the 3-D structures. The sequence corresponding Novel CBMs dictate E. rectale starch utilization 261 to each CBM was compared to the sequences of the CBM families listed in the CAZy database using BLAST (Altschul et al., 1990) .
